Frontlight ResearchEarly access
Not yet taking people in United StatesPhase 1
Nanopulse Laser Therapy
Key facts
- Who runs it
- The University of Texas Medical Branch, Galveston
- Where
- Galveston, United StatesSee the site
- Trial code
- Status
- Not yet recruiting
- Phase
- Phase 1
- People taking part
- 30 people, planned
- Starts
- 1 Dec 2026
- Expected to end
- May 2027
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Nano-Pulsed Laser Therapy (NPLT)
- Record updated
- 6 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Adults aged 18 years or older at the time of enrollment
- Confirmed diagnosis of moderate to severe TBI (clinical assessment and radiographic evidence)
- Admission to the neurosurgical or neurocritical care service with anticipated need for intracranial monitoring (e.g., microdialysis, ICP probe)
- Able to initiate treatment within 48 hours of admission
- Informed consent obtained from patient or legally authorized representative
Who cannot take part
- Known allergy or hypersensitivity to adhesives or device components
- Patients younger than 18 years of age
- Known or suspected pregnancy (verified via urine pregnancy test for females of childbearing age)
- Incarcerated individuals or prisoners
- Patients with pre-existing implanted cranial devices (e.g., deep brain stimulators) that may interfere with NPLT
- Patients with severe scalp injury or open wounds at intended treatment site
Where in United States
- University of Texas Medical BranchGalveston, United StatesContact: Patrick Karas, MDNot yet recruiting
About the trial
What the trial wants to find out
The purpose of this study is to evaluate the safety and effectiveness of a novel noninvasive therapy, Nanopulse Laser Therapy (NPLT), to improve recovery following traumatic brain injury (TBI).
The 2 groups in the trial
- Nano-Pulsed Laser Therapy (NPLT)Treatment being tested
Participants receive NPLT administered transcranially.
- Standard of Care with Sham NPLTNo study treatment, for comparison
Participants receive standard care with sham NPLT (laser delivery obstructed but device setup identical).
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Biomarker Responsiveness of Nanopulse Laser Therapy in Treatment of Traumatic Brain Injury
- Record updated
- 6 November 2026